Early cancer screening today and tomorrow: Exploring liquid biopsy profiling for diagnosis and treatment

Science AAAS
3/31/21, 3:00 PM
America/New York GMT -4 summer

Description

The early detection of a cancer is a critical factor in its characterization, treatment, and eventual elimination. Many cancers, however, grow undetected because we do not have a sufficiently accurate or sensitive means to detect them. In recent years, advances in the detection of cancer-specific DNA in the blood—so-called cell-free DNA (cfDNA)—have given clinicians hope that liquid biopsies might provide a minimally invasive way to identify primary cancers much sooner and to alert doctors to relapse following treatment by identifying minimal residual disease. The development of successful screening methods will get us ever closer to the goal of precision oncology. Challenges still remain, however, including finding ways to detect low-frequency mutations in cfDNA and to identify other DNA aberrations, such as copy-number alterations, breaks, and methylation changes. This webinar will explore advances in early cancer screening, including recent successes and new methodologies for cfDNA detection and analysis.

During this webinar, the speakers will:

  • Discuss the importance and clinical rationale for early cancer screening, providing examples from liver and pancreatic cancer
  • Explain how liquid biopsies from blood and other fluids can provide a valuable complement to current standard-of-care tests such as mammograms and colonoscopies
  • Discuss results from recent studies using some of the latest cfDNA detection methodologies
  • Explore potential clinical applications for early cancer screening as we move toward individualized patient treatment.
Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Sean Sanders

Early cancer screening today and tomorrow: Exploring liquid biopsy profiling for diagnosis and treatment

Inglês

 

Speakers

Anne Marie Lennon, Yuchen Jiao

 

Link to the Event

Banner to the Event

Early cancer screening today and tomorrow: Exploring liquid biopsy profiling for diagnosis and treatment